Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice

被引:45
作者
Bour-Jordan, W [1 ]
Thompson, HL [1 ]
Bluestone, JA [1 ]
机构
[1] Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA
关键词
D O I
10.4049/jimmunol.175.9.5649
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NOD mice deficient for the costimulatory molecule B7-2 (NOD-B7-2KO mice) are protected from autoimmune diabetes but develop a spontaneous autoimmune peripheral neuropathy that resembles human diseases Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Similar observations have now been made in conventional NOD mice. We have shown previously that this disease was mediated by autoreactive T cells inducing demyelination in the peripheral nervous system. In this study, we analyzed the molecular pathways involved in the disease. Our data showed that neuropathy developed in the absence of perforin or fas, suggesting that classic cytotoxicity pathways were dispensable for nerve damage in NOD-137-2KO mice. In contrast, IFN-gamma played an obligatory role in the development of neuropathy as demonstrated by the complete protection from disease and infiltration in the nerves in NOD-137-2KO mice deficient for IFN-gamma. This result was consistent with the inflammatory phenotype of T cells infiltrating the peripheral nerves. Importantly, the relative role of perforin, fas, and IFN-gamma appears completely different in autoimmune diabetes vs neuropathy. Thus, there are sharp contrasts in the pathogenesis of autoimmune diseases targeting different tissues in the same NOD background.
引用
收藏
页码:5649 / 5655
页数:7
相关论文
共 56 条
  • [11] The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile
    Dalakas, MC
    [J]. PHARMACOLOGY & THERAPEUTICS, 2004, 102 (03) : 177 - 193
  • [12] PREVENTION OF DIABETES IN NOD MICE TREATED WITH ANTIBODY TO MURINE IFN-GAMMA
    DEBRAYSACHS, M
    CARNAUD, C
    BOITARD, C
    COHEN, H
    GRESSER, I
    BEDOSSA, P
    BACH, JF
    [J]. JOURNAL OF AUTOIMMUNITY, 1991, 4 (02) : 237 - 248
  • [13] Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: Opposite roles of TNF receptor 1 and TNF receptor 2
    Fontaine, V
    Mohand-Said, S
    Hanoteau, N
    Fuchs, L
    Pfizenmaier, K
    Eisel, U
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (07)
  • [14] Plasmapheresis affects T helper type-1/T helper type-2 balance of circulating peripheral lymphocytes
    Goto, H
    Matsuo, H
    Nakane, S
    Izumoto, H
    Fukudome, T
    Kambara, C
    Shibuya, N
    [J]. THERAPEUTIC APHERESIS, 2001, 5 (06): : 494 - 496
  • [15] Elevated serum levels of IFN-γ, IL-4 and TNF-α/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage
    Hohnoki, K
    Inoue, A
    Koh, CS
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1998, 87 (1-2) : 27 - 32
  • [16] Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice
    Hultgren, B
    Huang, XJ
    Dybdal, N
    Stewart, TA
    [J]. DIABETES, 1996, 45 (06) : 812 - 817
  • [17] Interleukin-18 is induced in acute inflammatory demyelinating polyneuropathy
    Jander, S
    Stoll, G
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2001, 114 (1-2) : 253 - 258
  • [18] Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice
    Kagi, D
    Odermatt, B
    Seiler, P
    Zinkernagel, RM
    Mak, TW
    Hengartner, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) : 989 - 997
  • [19] Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system
    Kieseier, BC
    Kiefer, R
    Gold, R
    Hemmer, B
    Willison, HJ
    Hartung, HP
    [J]. MUSCLE & NERVE, 2004, 30 (02) : 131 - 156
  • [20] PARATHYROIDITIS IN THE NONOBESE DIABETIC MOUSE - A NEW FINDING
    KRUG, J
    WILLIAMS, AJK
    BEALES, PE
    DONIACH, I
    GALE, EAM
    POZZILLI, P
    [J]. JOURNAL OF ENDOCRINOLOGY, 1991, 131 (02) : 193 - &